1887

Chapter 5 : Viral Hepatitis

Authors: Andrew W. Tai, Jules L. Dienstag
Content Type: Reference
Publication Year: 2009

Category: Viruses and Viral Pathogenesis

MyBook is a cheap paperback edition of the original book and will be sold at uniform, low price.

Preview this chapter:
Preview Magnify
Zoom in
Zoomout

Viral Hepatitis, Page 1 of 2

| /docserver/preview/fulltext/10.1128/9781555815981/9781555814250_Chap05-1.gif /docserver/preview/fulltext/10.1128/9781555815981/9781555814250_Chap05-2.gif

Abstract:

This chapter discusses the typical clinical and pathological features of viral hepatitis as well as the suggested initial evaluation of a patient presenting with suspected viral hepatitis. Five different human hepatitis viruses have been recognized and characterized in detail. The five established agents are hepatitis A virus (HAV), hepatitis B virus (HBV), hepatitis C virus (HCV), hepatitis D virus (HDV), and hepatitis E virus (HEV), all RNA viruses, except for HBV, a DNA virus. Two observations established that epidemics of jaundice were caused by a filterable infectious agent, i.e., a virus. First, outbreaks of hepatitis in military personnel immunized with yellow fever vaccine were shown to have resulted from contamination of the vaccine by an agent in the serum used to supplement viral culture media. Second, viral hepatitis was transmissible to volunteers with filtered inocula. The clinical features and course of uncomplicated acute viral hepatitis are similar among the several types of viral hepatitis. Fatigue, malaise, and anorexia are common symptoms and can accompany all types of chronic viral hepatitis. In uncomplicated acute viral hepatitis, the reticulin framework is typically preserved. Acute viral hepatitis may also result from infections other than HAV to HEV. HCV RNA testing may be useful if chronic viral hepatitis is suspected but other serologic markers (including anti-HCV) are negative, particularly in immunocompromised individuals or those on chronic hemodialysis.

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5

Key Concept Ranking

Viral Liver Diseases
0.509138
Viral Hepatitis
0.49741673
Hepatitis B
0.43005008
Positive-Sense Single-Stranded RNA Viruses
0.40866444
Hepatitis C
0.4040323
0.509138
Highlighted Text: Show | Hide
Loading full text...

Full text loading...

Figures

Viral Hepatitis
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815981.ch05-1,webId=/content/author/10.1128/9781555815981.ch05-1,properties={foaf_givenname=Andrew W., foaf_name=Andrew W. Tai, foaf_surname=Tai}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815981.ch05-2,webId=/content/author/10.1128/9781555815981.ch05-2,properties={foaf_givenname=Jules L., foaf_name=Jules L. Dienstag, foaf_surname=Dienstag}]]
Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
/content/10.1128/9781555815981.ch05.ch05fig01
FIGURE 1
Round, eosinophilic Councilman bodies (arrow) signifying apoptosis of hepatocytes. (Courtesy of G. Y. Lauwers.)
10.1128/9781555815981/f0069-01_thmb.gif
10.1128/9781555815981/f0069-01.gif
Image of FIGURE 1
FIGURE 1

Round, eosinophilic Councilman bodies (arrow) signifying apoptosis of hepatocytes. (Courtesy of G. Y. Lauwers.)

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/10.1128/9781555815981.ch05.ch05fig02
FIGURE 2
Bridging necrosis (also known as interface hepatitis or piecemeal necrosis). An inflammatory infiltrate is visible within the portal tracts, spilling out into the hepatic lobule and resulting in piecemeal necrosis or interface hepatitis (white arrow). The hepatic lobule contains fat (black arrow) within hepatocytes, a common finding in viral hepatitis. (Courtesy of G. Y. Lauwers.)
10.1128/9781555815981/f0070-01_thmb.gif
10.1128/9781555815981/f0070-01.gif
Image of FIGURE 2
FIGURE 2

Bridging necrosis (also known as interface hepatitis or piecemeal necrosis). An inflammatory infiltrate is visible within the portal tracts, spilling out into the hepatic lobule and resulting in piecemeal necrosis or interface hepatitis (white arrow). The hepatic lobule contains fat (black arrow) within hepatocytes, a common finding in viral hepatitis. (Courtesy of G. Y. Lauwers.)

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/10.1128/9781555815981.ch05.ch05fig03
FIGURE 3
Cirrhosis resulting from chronic hepatitis C. The portal tracts contain numerous chronic inflammatory cells, which occasionally disrupt the limiting plate and spill out into the hepatocyte lobules (interface hepatitis). The lobules are separated from one another by fibrous septa to create nodules. (Courtesy of G. Y. Lauwers.)
10.1128/9781555815981/f0071-01_thmb.gif
10.1128/9781555815981/f0071-01.gif
Image of FIGURE 3
FIGURE 3

Cirrhosis resulting from chronic hepatitis C. The portal tracts contain numerous chronic inflammatory cells, which occasionally disrupt the limiting plate and spill out into the hepatocyte lobules (interface hepatitis). The lobules are separated from one another by fibrous septa to create nodules. (Courtesy of G. Y. Lauwers.)

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/10.1128/9781555815981.ch05.ch05fig04
FIGURE 4
Diagnostic approach to a patient with acute viral hepatitis.
10.1128/9781555815981/f0072-01_thmb.gif
10.1128/9781555815981/f0072-01.gif
Image of FIGURE 4
FIGURE 4

Diagnostic approach to a patient with acute viral hepatitis.

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint
/content/10.1128/9781555815981.ch05.ch05fig05
FIGURE 5
Diagnostic approach to a patient with chronic viral hepatitis.
10.1128/9781555815981/f0073-01_thmb.gif
10.1128/9781555815981/f0073-01.gif
Image of FIGURE 5
FIGURE 5

Diagnostic approach to a patient with chronic viral hepatitis.

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
Permissions and Reprints Request Permissions
Download as Powerpoint

References

/content/book/10.1128/9781555815981.ch05
1. Aach, R. D.,, C. E. Stevens,, F. B. Hollinger,, J. W. Mosley,, D. A. Peterson,, P. E. Taylor,, R. G. Johnson,, L. H. Barbosa, and, G. J. Nemo. 1991. Hepatitis C virus infection in post-transfusion hepatitis. An analysis with firstand second-generation assays. N. Engl. J. Med. 325: 1325– 1329.
2. Alter, H. J.,, P. V. Holland,, A. G. Morrow,, R. H. Purcell,, S. M. Feinstone, and, Y. Moritsugu. 1975. Clinical and serological analysis of transfusion-associated hepatitis. Lancet ii: 838– 841.
3. Alter, H. J.,, L. B. Seef,, P. M. Kaplan,, V. J. McAuliffe,, E. C. Wright,, J. L. Gerin,, R. H. Purcell,, P. V. Holland, and, H. J. Zimmerman. 1976. Type B hepatitis: the infectivity of blood positive for e antigen and DNA polymerase after accidental needlestick exposure. N. Engl. J. Med. 295: 909– 913.
4. Balayan, M. S.,, A. G. Andjaparidze,, S. S. Savinskaya,, E. S. Ketiladze,, D. M. Braginsky,, A. P. Savinov, and, V. F. Poleschuk. 1983. Evidence for a virus in non-A, non-B hepatitis transmitted via the fecal-oral route. Intervirology 20: 23– 31.
5. Baroudy, B. M.,, J. R. Ticehurst,, T. A. Miele,, J. V. Maizel, Jr.,, R. H. Purcell, and, S. M. Feinstone. 1985. Sequence analysis of hepatitis A virus cDNA coding for capsid proteins and RNA polymerase. Proc. Natl. Acad. Sci. USA 82: 2143– 2147.
6. Barrera, J. M.,, M. Bruguera,, M. G. Ercilla,, C. Gil,, R. Celis,, M. P. Gil,, M. del Valle Onorato,, J. Rodes, and, A. Ordinas. 1995. Persistent hepatitis C viremia after acute self-limiting posttransfusion hepatitis C. Hepatology 21: 639– 644.
7. Barrera, J. M.,, B. Francis,, G. Ercilla,, M. Nelles,, D. Achord,, J. Darner, and, S. R. Lee. 1995. Improved detection of anti-HCV in post-transfusion hepatitis by a third-generation ELISA. Vox Sang. 68: 15– 18.
8. Beasley, R. P.,, L. Y. Hwang,, G. C. Lee,, C. C. Lan,, C. H. Roan,, F. Y. Huang, and, C. L. Chen. 1983. Prevention of perinatally transmitted hepatitis B virus infections with hepatitis B immune globulin and hepatitis B vaccine. Lancet ii: 1099– 1102.
9. Beasley, R. P.,, L. Y. Hwang,, C. C. Lin, and, C. S. Chien. 1981. Hepatocellular carcinoma and hepatitis B virus: a prospective study of 22707 men in Taiwan. Lancet ii: 1129– 1132.
10. Benhamou, Y.,, M. Bochet,, V. Di Martino,, F. Charlotte,, F. Azria,, A. Coutellier,, M. Vidaud,, F. Bricaire,, P. Opolon,, C. Katlama, and, T. Poynard for the MULTIVIRC Group. 1999. Liver fibrosis progression in human immunodeficiency virus and hepatitis C virus coinfected patients. Hepatology 30: 1054– 1058.
11. Bertoletti, A.,, C. Ferrari,, F. Fiaccodori,, A. Penna,, R. Margolskee,, H. Schlicht,, P. Fowler,, S. Guilhot, and, F. V. Chisari. 1991. HLA class 1-restricted cytotoxic T cells recognize endogenously synthesized hepatitis B virus nucleocapsid antigen. Proc. Natl. Acad. Sci. USA 88: 10445– 10449.
12. Bjoro, K.,, S. S. Froland,, Z. Yun,, H. H. Samdal, and, T. Haaland. 1994. Hepatitis C infection in patients with primary hypogammaglobulinemia after treatment with contaminated immune globulin. N. Engl. J. Med. 331: 1607– 1611.
13. Blackwell Publishing. 1999. Global surveillance and control of hepatitis C. Report of a WHO Consultation organized in collaboration with the Viral Hepatitis Prevention Board, Antwerp, Belgium. J. Viral Hepat. 6: 35– 47.
14. Blumberg, B. S.,, H. J. Alter, and, S. Visnich. 1965. A “new” antigen in leukemia sera. JAMA 191: 541– 546.
15. Blumer, G. 1923. Infectious jaundice in the United States. JAMA 81: 353– 358.
16. Bradley, D. W. 1992. Hepatitis E: epidemiology, aetiology and molecular biology. Rev. Med. Virol. 2: 19– 28.
17. Brunetto, M. R.,, M. Stemler, and, F. Schodel. 1989. Identification of HBV variant which cannot produce pre-core derived HBeAg and may be responsible for severe hepatitis. Ital. J. Gastroenterol. 21: 151– 154.
18. Burrell, C. J.,, P. Mackay,, P. J. Grennaway,, P. H. Hofschneider, and, K. Murray. 1979. Expression in Escherichia coli of hepatitis B virus sequences cloned in plasmid pBR-322. Nature 279: 43– 47.
19. Cacheux, W.,, N. Carbonell,, O. Rosmorduc,, D. Wendum,, F. Paye,, R. Poupon,, O. Chazouillères, and, J. Gozlan. 2005. HHV-6-related acute liver failure in two immunocompetent adults: favourable outcome after liver transplantation and/or ganciclovir therapy. J. Intern. Med. 258: 573– 578.
20. Chang, M. H.,, C. J. Chen,, M. S. Lai,, H. M. Hsu,, T. C. Wu,, M. S. Kong,, D. C. Liang,, W. Y. Shau, and, D. S. Chen for the Taiwan Childhood Hepatoma Study Group. 1997. Universal hepatitis B vaccination in Taiwan and the incidence of hepatocellular carcinoma in children. N. Engl. J. Med. 336: 1855– 1859.
21. Charnay, P.,, C. Pourcel,, A. Louise,, A. Fritsch, and, P. Tiollais. 1979. Cloning in Escherichia coli and physical structure of hepatitis B virion DNA. Proc. Natl. Acad. Sci. USA 76: 2222– 2226.
22. Chisari, F. W.,, K. Hopchin,, T. Moriyama,, C. Pasquinelli,, H. A. Dunsford,, S. Sells, and, C. A. Pinkert. 1989. Molecular pathogenesis of hepatocellular carcinoma in hepatitis B virus transgenic mice. Cell 59: 1145– 1156.
23. Choo, Q. L.,, G. Kuo,, A. J. Weiner,, L. R. Overby,, D. W. Bradley, and, M. Houghton. 1989. Isolation of a cDNA clone derived from a blood borne non-A, non-B viral hepatitis genome. Science 244: 359– 362.
24. Chung, R. T.,, J. Andersen,, P. Volberding,, G. K. Robbins,, T. Liu,, K. E. Sherman,, M. G. Peters,, M. J. Koziel,, A. K. Bhan,, B. Alston,, D. Colquhoun,, T. Nevin,, G. Harb,, C. van der Horst, and AIDS Clinical Trials Group A5071 Study Team. 2004. Peginterferon alfa-2a plus ribavirin versus interferon alfa-2a plus ribavirin for chronic hepatitis C in HIV-coinfected persons. N. Engl. J. Med. 351: 451– 459.
25. Clemens, R.,, A. Safary,, A. Hepburn,, C. Roche,, W. J. Stanbury, and, F. E. André. 1995. Clinical experience with an inactivated hepatitis A vaccine. J. Infect. Dis. 171: S44– S49.
26. Clifford, B. D.,, D. Donahue,, L. Smith,, E. Cable,, B. Luttig,, M. Manns, and, H. L. Bonkovsky. 1995. High prevalence of serological markers of autoimmunity in patients with chronic hepatitis C. Hepatology 21: 613– 619.
27. Cohen, J. I.,, J. R. Ticehurst,, R. H. Purcell,, A. Buckler-White, and, B. M. Baroudy. 1987. Complete nucleotide sequence of wild-type hepatitis A virus: comparison with different strains of hepatitis A virus and other picornaviruses. J. Virol. 61: 50– 59.
28. Colin, J. F.,, D. Cazals-Hatem,, M. A. Loriot,, M. Martinot-Peignoux,, B. N. Pham,, A. Auperin,, C. Degott,, J. P. Benhamou,, S. Erlinger,, D. Valla, and, P. Marcellin. 1999. Influence of human immunodeficiency virus infection on chronic hepatitis B in homosexual men. Hepatology 29: 1306– 1310.
29. Conte, D.,, M. Fraquelli,, D. Prati,, A. Colucci, and, E. Minola. 2000. Prevalence and clinical course in chronic hepatitis C virus (HCV) infection and rate of HCV vertical transmission in a cohort of 15,250 pregnant women. Hepatology 31: 751– 755.
30. Czaja, A. J. 1992. Chronic hepatitis C virus infection—a disease in waiting? N. Engl. J. Med. 327: 1949– 1950.
31. Dane, D. S.,, C. H. Cameron, and, M. Briggs. 1970. Virus-like particles in serum of patients with Australia antigen associated hepatitis. Lancet ii: 695– 698.
32. Davern, T. J.,, L. P. James,, J. A. Hinson,, J. Polson,, A. M. Larson,, R. J. Fontana,, E. Lalani,, S. Munoz,, A. O. Shakil,, W. M. Lee, and Acute Liver Failure Study Group. 2006. Measurement of serum acetaminophen-protein adducts in patients with acute liver failure. Gastroenterology 130: 687– 694.
33. Davies, S. E.,, B. C. Portmann,, J. G. O’Grady,, P. M. Aldis,, K. Chaggar,, G. J. Alexander, and, R. Williams. 1991. Hepatic histological findings after transplantation for chronic hepatitis B virus infection, including a unique pattern of fibrosing cholestatic hepatitis. Hepatology 13: 150– 157.
34. Dawson, G. J.,, K. H. Chau,, C. M. Cabal,, P. O. Yarbough,, G. R. Reyes, and, I. K. Mushahwar. 1992. Solidphase enzyme-linked immunosorbent assay for hepatitis E virus IgG and IgM antibodies utilizing recombinant antigens and synthetic peptides. J. Virol. Methods 38: 175– 186.
35. Deinhardt, F.,, A. W. Holmes,, R. B. Capps, and, H. Popper. 1967. Studies on the transmission of viral hepatitis to marmoset monkeys. I. Transmission of disease, serial passage, and descriptions of liver lesions. J. Exp. Med. 125: 673– 688.
36. DiBisceglie, A. M.,, S. E. Order,, J. L. Klein,, J. G. Waggoner,, M. H. Sjogren,, G. Kuo,, M. Houghton,, Q. L. Choo, and, J. H. Hoofnagle. 1991. The role of chronic viral hepatitis in hepatocellular carcinoma in the United States. Am. J. Gastroenterol. 86: 335– 338.
37. Di Martino, V.,, P. Rufat,, N. Boyer,, P. Renard,, F. Degos,, M. Martinot-Peignoux,, S. Matheron,, V. Le Moing,, F. Vachon,, C. Degott,, D. Valla, and, P. Marcellin. 2001. The influence of human immunodeficiency virus coinfection on chronic hepatitis C in injection drug users: a long-term retrospective cohort study. Hepatology 34: 1193– 1199.
38. Dusheiko, G. M. 1994. Rolling review—the pathogenesis, diagnosis and management of viral hepatitis. Aliment. Pharmacol. Ther. 8: 229– 253.
39. Elinav, E.,, I. Z. Ben-Dov,, Y. Shapira,, N. Daudi,, R. Adler,, D. Shouval, and, Z. Ackerman. 2006. Acute hepatitis A infection in pregnancy is associated with high rates of gestational complications and preterm labor. Gastroenterology 130: 1129– 1134.
40. Fabrizi, F.,, P. Martin,, V. Dixit,, F. Kanwal, and, G. Dulai. 2005. HBsAg seropositive status and survival after renal transplantation: meta-analysis of observational studies. Am. J. Transplant. 5: 2913– 2921.
41. Fagan, E. A. 1994. Acute liver failure of unknown pathogenesis: the hidden agenda. Hepatology 19: 1307– 1312.
42. Fattovich, G.,, G. Giustina,, E. Christensen,, M. Pantalena,, I. Zagni,, G. Realdi,, S. W. Schalm, and The European Concerted Action on Viral Hepatitis (Eurohep). 2000. Influence of hepatitis delta virus infection on morbidity and mortality in compensated cirrhosis type B. Gut 46: 420– 426.
43. Feinstone, S.,, A. Kapikian,, R. Purcell,, H. Alter, and, P. Holland. 1975. Transfusion-associated hepatitis not due to viral hepatitis type A or B. N. Engl. J. Med. 292: 767– 770.
44. Feinstone, S. M.,, A. Z. Kapikian, and, R. H. Purcell. 1973. Hepatitis A: detection by immune electron microscopy of a virus-like antigen associated with acute illness. Science 182: 1026– 1028.
45. Gerlach, J. T.,, H. M. Diepolder,, R. Zachoval,, N. H. Gruener,, M. C. Jung,, A. Ulsenheimer,, W. W. Schraut,, C. A. Schirren,, M. Waechtler,, M. Backmund, and, G. R. Pape. 2003. Acute hepatitis C: high rate of both spontaneous and treatment-induced viral clearance. Gastroenterology 125: 80– 88.
46. Gilson, R. J.,, A. E. Hawkins,, M. R. Beecham,, E. Ross,, J. Waite,, M. Briggs,, T. McNally,, G. E. Kelly,, R. S. Tedder, and, I. V. Weller. 1997. Interactions between HIV and hepatitis B virus in homosexual men: effects on the natural history of infection. AIDS 11: 597– 606.
47. Gisbert, J. P.,, L. García-Buey,, J. M. Pajares, and, R. Moreno-Otero. 2003. Prevalence of hepatitis C virus infection in B-cell non-Hodgkin’s lymphoma: systematic review and meta-analysis. Gastroenterology 125: 1723– 1732.
48. Gocke, D. J. 1978. Immune complex phenomena associated with hepatitis, p. 277–283. In G. N. Vyas,, S. N. Cohen, and, R. Schmid (ed.), Viral Hepatitis: a Contemporary Assessment of Etiology, Epidemiology, Pathogenesis and Prevention. The Franklin Institute Press, Philadelphia, PA.
49. Goodman, Z. D.,, and K. G. Ishak. 1995. Histopathology of hepatitis C virus infection. Semin. Liver Dis. 15: 70– 81.
50. Govindarajan, S.,, K. P. Chin,, A. G. Redeker, and, R. L. Peters. 1984. Fulminant B viral hepatitis: role of delta agent. Gastroenterology 86: 1417– 1420.
51. Hadler, S. C.,, M. De Monzon,, A. Ponzetto,, E. Anzola,, D. Rivero,, A. Mondolfi,, A. Bracho,, D. P. Francis,, M. A. Gerber,, S. Thung,, J. Gerin,, J. E. Maynard,, H. Popper, and, R. H. Purcell. 1984. Delta virus infection and severe hepatitis: an epidemic in Yupca Indians of Venezuela. Ann. Intern. Med. 100: 339– 344.
52. Hernandez, M. E.,, M. Bruguera,, T. Puyuelo,, J. M. Barrera,, J. M. Sanchez Tapias, and, J. Rodes. 1992. Risk of needlestick injuries in the transmission of hepatitis C virus in hospital personnel. J. Hepatol. 16: 56– 58.
53. Holmes, A.,, L. Wolfe,, H. Rosenblate, and, F. Deinhardt. 1969. Hepatitis in marmosets: induction of disease and coded specimens. Science 165: 816– 817.
54. Ishak, K.,, A. Baptista,, L. Bianchi,, F. Callea,, J. De Groote,, F. Gudat,, H. Denk,, V. Desmet,, G. Korb,, R. N. M. MacSween,, M. J. Phillips,, B. G. Portmann,, H. Poulsen,, P. J. Scheuer,, M. Schmid, and, H. Thaler. 1995. Histological grading and staging of chronic hepatitis. J. Hepatol. 22: 696– 699.
55. Iwarson, S.,, G. Norkrans, and, R. Wejstal. 1995. Hepatitis C: natural history of a unique infection. Clin. Infect. Dis. 20: 1361– 1370.
56. Kao, J. H.,, and D. S. Chen. 2002. Global control of hepatitis B virus infection. Lancet Infect. Dis. 2: 395– 403.
57. Kao, J. H.,, P. J. Chen,, M. Y. Lai, and, D. S. Chen. 2000. Hepatitis B genotypes correlate with clinical outcomes in patients with chronic hepatitis B. Gastroenterology 118: 554– 559.
58. Katelaris, P. H.,, and D. B. Jones. 1989. Fulminant hepatic failure. Med. Clin. N. Am. 73: 955– 970.
59. Kempinska, A.,, E. J. Kwak, and, J. B. Angel. 2005. Reactivation of hepatitis B infection following allogeneic bone marrow transplantation in a hepatitis B-immune patient: case report and review of the literature. Clin. Infect. Dis. 41: 1277– 1282.
60. Knodell, K. G.,, K. G. Ishak,, W. C. Black,, T. S. Chen,, N. Kaplowitz,, T. W. Kiernan, and, J. Wollman. 1981. Formulation and application of a numerical scoring system for assessing histological activity in asymptomatic chronic active hepatitis. Hepatology 1: 432– 435.
61. Kohrt, H. E.,, D. L. Ouyang, and, E. B. Keeffe. 2006. Systematic review: lamivudine prophylaxis for chemotherapy-induced reactivation of chronic hepatitis B virus infection. Aliment. Pharmacol. Ther. 24: 1003– 1016.
62. Koziel, M. J.,, D. Dudley,, N. Afdhal,, Q. L. Choo,, M. Houghton,, R. Ralston, and, B. D. Walker. 1993. Hepatitis C virus (HCV)-specific cytotoxic T lymphocytes recognize epitopes in the core and envelope proteins of HCV. J. Virol. 67: 7522– 7532.
63. Krugman, S.,, J. Giles, and, J. Hammond. 1970. Hepatitis virus: effect of heat on the infectivity and antigenicity of the MS-a and MS-2 strains. J. Infect. Dis. 122: 432.
64. Krugman, S.,, J. Giles, and, J. Hammond. 1971. Viral hepatitis type B (MS-2 strain): studies on active immunization. JAMA 217: 41.
65. Krugman, S.,, J. P. Giles, and, J. Hammond. 1967. Infectious hepatitis: evidence for two distinctive clinical, epidemiological and immunological types of infection. JAMA 200: 365– 373.
66. Kumar, A.,, M. Beniwal,, P. Kar,, J. B. Sharma, and, N. S. Murthy. 2004. Hepatitis E in pregnancy. Int. J. Gynecol. Obstet. 85: 240– 244.
67. Leary, T. P.,, A. S. Muerhoff,, J. N. Simons,, T. J. Pilot-Matias,, J. C. Erker,, M. L. Chalmers,, G. G. Schlauder,, G. J. Dawson,, S. M. Desai, and, I. K. Mushahwar. 1996. Sequence and genomic organization of GBV-C: a novel member of the flaviviridae associated with human non-A-E hepatitis. J. Med. Virol. 48: 60– 67.
68. Lenzi, M.,, G. Ballardini,, M. Fusconi,, F. Cassani,, L. Selleri,, U. Volta,, D. Zauli, and, F. B. Bianchi. 1990. Type 2 autoimmune hepatitis and hepatitis C virus infection. Lancet 335: 258– 259.
69. Liang, T. J.,, K. Hasegawa,, N. Rimon,, J. R. Wands, and, E. Ben-Porath. 1991. A hepatitis B virus mutant associated with an epidemic of fulminant hepatitis. N. Engl. J. Med. 324: 1705– 1709.
70. Liang, T. J.,, L. Jeffers,, R. K. Reddy,, M. O. Silva,, H. Cheinquer,, A. Findor,, M. De Medina,, P. O. Yarbough,, G. R. Reyes, and, E. R. Schiff. 1993. Fulminant or subfulminant non-A, non-B viral hepatitis: the role of hepatitis C and E viruses. Gastroenterology 104: 556– 562.
71. Linnen, J.,, J. Wages,, Z. Y. Zhang-Keck,, K. E. Fry,, K. Z. Krawczynski,, H. Alter,, E. Koonin,, M. Gallagher,, M. Alter,, S. Hadziyannis,, P. Karayiannis,, K. Fung,, Y. Nakatsuji,, J. W. Shih,, L. Young,, M. Piatak,, C. Hoover,, J. Fernandez,, S. Chen,, J. C. Zou,, T. Morris,, K. C. Hyams,, S. Ismay,, J. D. Lifson,, G. Hess,, S. K. Foung,, H. Thomas,, D. Bradley,, H. Margolis, and, J. P. Kim. 1996. Molecular cloning and disease association of hepatitis G virus: a transfusion-transmissible agent. Science 271: 505– 508.
72. Lou, S.,, X. Qiu,, G. Tegtmeier,, S. Leitza,, J. Brackett,, K. Cousineau,, A. Varma,, H. Seballos,, S. Kundu,, S. Kuemmerle, and, J. Hunt. 1997. Immunoassays to study prevalence of antibody against GB virus C in blood donors. J. Virol. Methods 68: 45– 55.
73. Louie, J. K.,, L. C. Hsu,, D. H. Osmond,, M. H. Katz, and, S. K. Schwarcz. 2002. Trends in causes of death among persons with acquired immunodeficiency syndrome in the era of highly active antiretroviral therapy, San Francisco, 1994–1998. J. Infect. Dis. 186: 1023– 1027.
74. Lunel, F.,, L. Musset,, P. Cacoub,, L. Frangeul,, P. Cresta,, M. Perrin,, P. Grippon,, C. Hoang,, J. C. Piette,, J. M. Huraux, and, P. Opolon. 1994. Cryoglobulinemia in chronic liver diseases: role of hepatitis C virus and liver damage. Gastroenterology 106: 1291– 1300.
75. MacCallum, F. O.,, and D. J. Bauer. 1944. Homologous serum jaundice: transmission experiments with human volunteers. Lancet i: 622– 627.
76. Magnone, M.,, J. L. Holley,, R. Shapiro,, V. Scantlebury,, J. McCauley,, M. Jordan,, C. Vivas,, T. Starzl, and, J. P. Johnson. 1995. Interferon-alpha-induced acute renal allograft rejection. Transplantation 59: 1068– 1070.
77. Mast, E. E.,, and M. J. Alter. 1993. Epidemiology of viral hepatitis: an overview. Semin. Virol. 4: 273– 283.
78. McIntyre, P. G.,, K. Tosh, and, W. McGuire. 2006. Caesarean section versus vaginal delivery for preventing mother to infant hepatitis C virus transmission. Cochrane Database of Systematic Reviews CD005546.
79. Miller, M. F.,, C. Haley,, M. J. Koziel, and, C. F. Rowley. 2005. Impact of hepatitis C virus on immune restoration in HIV-infected patients who start highly active anti-retroviral therapy: a meta-analysis. Clin. Infect. Dis. 41: 713– 720.
80. Misiani, R.,, P. Bellavita,, D. Fenili,, G. Borelli,, D. Marchesi,, M. Massazza,, G. Vendramin,, B. Comotti,, E. Tanzi,, G. Scudeller, and, A. Zanetti. 1992. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann. Intern. Med. 117: 573– 577.
81. Munoz, S. J.,, D. W. Bradley,, P. Martin,, K. Krawczynski,, M. A. Purdy, and, S. Westerberg. 1992. Hepatitis E virus found in patients with apparent fulminant non-A, non-B hepatitis. Hepatology 16: 76A.
82. Naidu, S.,, and R. Viewanath. 1957. Infectious hepatitis in Delhi 1955–1956: a critical study; observations in pregnant women. Indian J. Med. Res. 45: 71– 76.
83. Nakashima, K.,, S. Kashiwagi,, J. Hayashi,, A. Noguchi,, M. Hirata,, W. Kajiyama,, K. Urabe,, K. Minami, and, Y. Maeda. 1992. Sexual transmission of hepatitis C virus among female prostitutes and patients with sexually transmitted diseases in Fukuoka, Kyushu, Japan. Am. J. Epidemiol. 136: 1132– 1137.
84. National Institutes of Health. 2002. Management of hepatitis C: 2002. NIH Consens. State Sci. Statements 19: 1– 46.
85. Nishizawa, T.,, H. Okamoto,, K. Konishi,, H. Yoshizawa,, Y. Miyakawa, and, M. Mayumi. 1997. A novel DNA virus (TTV) associated with elevated transaminase levels in posttransfusion hepatitis of unknown etiology. Biochem. Biophys. Res. Commun. 14: 92– 97.
86. Patra, S.,, A. Kumar,, S. S. Trivedi,, M. Puri, and, S. K. Sarin. 2007. Maternal and fetal outcomes in pregnant women with acute hepatitis E virus infection. Ann. Intern. Med. 147: 28– 33.
87. Pineda, J. A.,, M. Romero-Goméz,, F. Díaz-García,, J. A. Girón-González,, J. L. Montero,, J. Torre-Cisneros,, R. J. Andrade,, M. González-Serrano,, J. Aguilar,, M. Aguilar-Guisado,, J. M. Navarro,, J. Salmerón,, F. J. Caballero-Granado,, J. A. García-García, Grupo Andaluz para el Estudio de las Enfermedades Infecciosas, and Grupo Analuz para el Estudio del Hígado. 2005. HIV coinfection shortens the survival of patients with hepatitis C virus-related decompensated cirrhosis. Hepatology 41: 779– 789.
88. Piroth, L.,, D. Sène,, S. Pol,, I. Goderel,, K. Lacombe,, B. Martha,, D. Rey,, V. Loustau-Ratti,, J. F. Bergmann,, G. Pialoux,, A. Gervais,, C. Lascoux-Combe,, F. Carrat, and, P. Cacoub. 2007. Epidemiology, diagnosis and treatment of chronic hepatitis B in HIV-infected patients (EPIB 2005 STUDY). AIDS 21: 1323– 1331.
89. Prince, A. M. 1968. An antigen detected in the blood during the incubation period of serum hepatitis. Proc. Natl. Acad. Sci. USA 60: 814– 821.
90. Prince, A. M.,, J. W. Scheffel, and, B. Moore. 1997. A search for hepatitis C virus polymerase chain reaction-positive but seronegative subjects among blood donors with elevated alanine aminotransferase. Transfusion (Paris) 37: 211– 214.
91. Rendina, M.,, A. Schena,, N. M. Castellaneta,, F. Losito,, A. C. Amoruso,, G. Stallone,, F. P. Schena,, A. Di Leo, and, A. Francavilla. 2007. The treatment of chronic hepatitis C with peginterferon alfa-2a (40 kDa) plus ribavirin in haemodialysed patients awaiting renal transplant. J. Hepatol. 46: 768– 774.
92. Reyes, G. R.,, M. A. Purdy,, J. P. Kim,, K. C. Luk,, L. M. Young,, K. E. Fry, and, D. W. Bradley. 1990. Isolation of a cDNA from the virus responsible for enterically transmitted non-A, non-B hepatitis. Science 247: 1335– 1339.
93. Rizzetto, M.,, M. G. Canese,, S. Arico,, O. Crivelli,, F. Bonino,, C. G. Trepo, and, G. Verme. 1977. Immunofluorescence detection of a new antigen-antibody system (δ/anti-δ) associated with the hepatitis B virus in the liver and in the serum of HBsAg carriers. Gut 18: 997– 1003.
94. Rizzetto, M.,, J. W. Shih, and, J. L. Gerin. 1980. The hepatitis B virus-associated delta antigen: isolation from liver, development of solid-phase radioimmunoassays for delta antigen and anti-delta and partial characterization of delta antigen. J. Immunol. 125: 318– 324.
95. Roth, W. K.,, D. Waschk,, S. Marx,, S. Tschauder,, S. Zeuzem,, H. Bialleck,, H. Weber, and, E. Seifried. 1997. Prevalence of hepatitis G virus and its strain variant, the GB agent, in blood donations and their transmission to recipients. Transfusion (Paris) 37: 651– 656.
96. Santantonio, T.,, E. Medda,, C. Ferrari,, P. Fabris,, G. Cariti,, M. Massari,, S. Babudieri,, M. Toti,, R. Francavilla,, F. Ancarani,, G. Antonucci,, G. Scotto,, V. Di Marco,, G. Pastore, and, T. Stroffolini. 2006. Risk factors and outcome among a large patient cohort with community-acquired acute hepatitis C in Italy. Clin. Infect. Dis. 43: 1154– 1159.
97. Schreiber, G. B.,, M. P. Busch,, S. H. Kleinman, and, J. J. Korelitz. 1996. The risk of transfusion transmitted viral infection. N. Engl. J. Med. 334: 1685– 1690.
98. Seeff, L. B. 2002. Natural history of chronic hepatitis C. Hepatology 36: S35– S46.
99. Seeff, L. B.,, E. C. Wright,, H. J. Zimmerman,, H. J. Alter,, A. A. Dietz,, B. F. Felsher,, J. D. Finkelstein,, P. Garcia-Pont,, J. L. Gerin,, H. B. Greenlee,, J. Hamilton,, P. V. Holland,, P. M. Kaplan,, T. Kiernan,, R. S. Koff,, C. M. Leevy,, V. J. McAuliffe,, N. Nath,, R. H. Purcell,, E. R. Schiff,, C. C. Schwartz,, C. H. Tamburro,, Z. Vlahcevic,, R. Zemel, and, D. S. Zimmon. 1978. Type B hepatitis after needle-stick exposure: prevention with hepatitis B immune globulin. Final report of the Veterans Administration Cooperative Study. Ann. Intern. Med. 88: 285– 293.
100. Silva, A. E.,, B. J. McMahon,, A. J. Parkinson,, M. H. Sjogren,, J. H. Hoofnagle, and, A. M. Di Bisceglie. 1998. Hepatitis B virus DNA in persons with isolated antibody to hepatitis B core antigen who subsequently received hepatitis B vaccine. Clin. Infect. Dis. 26: 895– 897.
101. Simonetti, R. G.,, C. Camma,, F. Fiorello,, M. Cottone,, M. Rapicetta,, L. Marino,, G. Fiorentino,, A. Craxi,, A. Ciccaglione,, R. Giuseppetti,, T. Stroffolini, and, L. Pagliaro. 1992. Hepatitis C virus infection as a risk factor for hepatocellular carcinoma in patients with cirrhosis. Ann. Intern. Med. 116: 97– 102.
102. Simons, J. N.,, T. J. Pilot-Matias,, T. P. Leary,, G. J. Dawson, and, S. M. Desai. 1995. Identification of two flavivirus-like genomes in the GB hepatitis agent. Proc. Natl. Acad. Sci. USA 92: 3401– 3405.
103. Smedile, A.,, G. Verme,, A. Cargnel,, P. Dentico,, P. Opolon,, D. Vergani,, P. Farci,, F. Caredda,, N. Caporaso,, C. Trepo,, A. Gimson,, R. Williams, and, M. Rizzetto. 1982. Influence of delta infection on severity of hepatitis B. Lancet ii: 945– 947.
104. Sninsky, J. J.,, A. Siddiqui,, W. S. Robinson, and, S. N. Cohen. 1979. Cloning and endonuclease mapping of the hepatitis B viral genome. Nature 279: 346– 348.
105. Szmuness, W.,, C. E. Stevens,, E. J. Harley,, E. A. Zang,, W. R. Oleszko,, D. C. William,, R. Sadovsky,, J. M. Morrison, and, A. Kellner. 1980. Hepatitis B vaccine: demonstration of efficacy in a controlled clinical trial in a high-risk population in the United States. N. Engl. J. Med. 303: 833– 841.
106. Tabor, E.,, R. J. Gerety,, J. A. Drucker,, L. B. Seeff,, J. H. Hoofnagle,, D. R. Jackson,, M. April,, L. F. Barker, and, G. Pineda-Tamondong. 1978. Transmission of nonA, non-B hepatitis from man to chimpanzee. Lancet ii: 463– 466.
107. Taylor, R. M.,, T. Davern,, S. Munoz,, S. H. Han,, B. McGuire,, A. M. Larson,, L. Hynan,, W. M. Lee,, R. J. Fontana, and U.S. Acute Liver Failure Study Group. 2006. Fulminant hepatitis A virus infection in the United States: incidence, prognosis, and outcomes. Hepatology 44: 1589– 1597.
108. Tedder, R. S.,, R. J. Gilson,, M. Briggs,, C. Loveday,, C. H. Cameron,, J. A. Garson,, G. E. Kelly, and, I. V. Weller. 1991. Hepatitis C virus: evidence for sexual transmission. Br. Med. J. 302: 1299– 1302.
109. Tei, S.,, N. Kitajima,, K. Takahashi, and, S. Mishiro. 2003. Zoonotic transmission of hepatitis E virus from deer to human beings. Lancet 362: 371– 373.
110. Thomas, D. L.,, J. M. Zenilman,, H. J. Alter,, J. W. Shih,, N. Galai,, A. V. Carella, and, T. C. Quinn. 1995. Sexual transmission of hepatitis C virus among patients attending sexually transmitted diseases clinics in Baltimore—an analysis of 309 sex partnerships. J. Infect. Dis. 171: 768– 775.
111. Thomas, S. L.,, M. L. Newell,, C. S. Peckham,, A. E. Ades, and, A. J. Hall. 1998. A review of hepatitis c virus (HCV) vertical transmission: risks of transmission to infants born to mothers with and without HCV viraemia or human immunodeficiency virus infection. Int. J. Epidemiol. 27: 108– 117.
112. Torriani, F. J.,, M. Rodriguez-Torres,, J. K. Rockstroh,, E. Lissen,, J. Gonzalez-García,, A. Lazzarin,, G. Carosi,, J. Sasadeusz,, C. Katlama,, J. Montaner,, H. Sette, Jr.,, S. Passe,, J. De Pamphilis,, F. Duff,, U. M. Schrenk, and, D. T. Dieterich for the APRICOT Study Group. 2004. Peginterferon alfa-2a plus ribavirin for chronic hepatitis C virus infection in HIV-infected patients. N. Engl. J. Med. 351: 438– 450.
113. U.S. Public Health Service. 2001. Updated U.S. Public Health Service Guidelines for the management of occupational exposures to HBV, HCV, and HIV and recommendations for postexposure prophylaxis. Morb. Mortal. Wkly. Rep. Recomm. Rep. 50: 1– 52.
114. Valenzuela, P.,, P. Gray,, M. Quiroga,, J. Zaldivar,, H. M. Goodman, and, W. J. Rutter. 1979. Nucleotide sequence of the gene coding for the major protein of hepatitis B virus surface antigen. Nature 280: 815– 819.
115. van Zonneveld, M.,, A. B. van Nunen,, H. G. Niesters,, R. A. de Man,, S. W. Schalm, and, H. L. Janssen. 2003. Lamivudine treatment during pregnancy to prevent perinatal transmission of hepatitis B virus infection. J. Viral Hepat. 10: 294– 297.
116. Wands, J. R.,, E. Mann,, E. Alpert, and, K. J. Isselbacher. 1975. The pathogenesis of arthritis associated with acute hepatitis-B surface antigen-positive hepatitis: complement activation and characterization of circulating immune complexes. J. Clin. Investig. 55: 930– 936.
117. Wasley, A.,, and M. J. Alter. 2000. Epidemiology of hepatitis C: geographic differences and temporal trends. Semin. Liver Dis. 21: 1– 16.
118. Wasley, A.,, J. T. Miller,, L. Finelli, and Centers for Disease Control and Prevention (CDC). 2007. Surveillance for acute viral hepatitis—United States, 2005. Morb. Mortal. Wkly. Rep. CDC Surveill. Summ. 16: 1– 24.
119. Weinstock, H. S.,, G. Bolan,, A. L. Reingold, and, L. B. Polish. 1993. Hepatitis C virus infection among patients attending a clinic for sexually transmitted diseases. JAMA 269: 392– 394.
120. Wong, D. C.,, R. H. Purcell,, M. A. Sreenivasan,, S. R. Prasad, and, K. M. Pavri. 1980. Epidemic and endemic hepatitis in India: evidence for a non-A, non-B hepatitis aetiology. Lancet ii: 876– 879.
121. Wright, T. L.,, D. Mamish,, C. Combs,, M. Kim,, E. Donegan,, L. Ferrell,, J. Lake,, J. Roberts, and, N. L. Ascher. 1992. Hepatitis B virus and apparent fulminant non-A and non-B hepatitis. Lancet 339: 952– 955.
122. Yeo, W.,, B. Zee,, S. Zhong,, P. K. Chan,, W. L. Wong,, W. M. Ho,, K. C. Lam, and, P. J. Johnson. 2004. Comprehensive analysis of risk factors associating with hepatitis B virus (HBV) reactivation in cancer patients undergoing cytotoxic chemotherapy. Br. J. Cancer 90: 1306– 1311.
123. Zuckerman, E.,, T. Zuckerman,, D. Douer,, D. Qian, and, A. M. Levine. 1998. Liver dysfunction in patients infected with hepatitis C virus undergoing chemotherapy for hematologic malignancies. Cancer 83: 1224– 1230.

Tables

Viral Hepatitis
[com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815981.ch05-1,webId=/content/author/10.1128/9781555815981.ch05-1,properties={foaf_givenname=Andrew W., foaf_name=Andrew W. Tai, foaf_surname=Tai}], com.pub2web.rdf.cci.facet.ContentItem[id=http://asm.metastore.ingenta.com/content/author/10.1128/9781555815981.ch05-2,webId=/content/author/10.1128/9781555815981.ch05-2,properties={foaf_givenname=Jules L., foaf_name=Jules L. Dienstag, foaf_surname=Dienstag}]]
Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
/content/10.1128/9781555815981.ch05.ch05tab01
TABLE 1
Clinical and epidemiological features of viral hepatitis
Generic image for table
TABLE 1

Clinical and epidemiological features of viral hepatitis

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5
/content/10.1128/9781555815981.ch05.ch05tab02
TABLE 2
Common serologic patterns and their interpretations
Generic image for table
TABLE 2

Common serologic patterns and their interpretations

Citation: Tai A, Dienstag J. 2009. Viral Hepatitis, p 59-80. In Richman D, Whitley R, Hayden F (ed), Clinical Virology, Third Edition. ASM Press, Washington, DC. doi: 10.1128/9781555815981.ch5

Back to top
This is a required field
Please enter a valid email address
Please check the format of the address you have entered.
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error